Sell, Sell, Sell | GenomeWeb

Sell, Sell, Sell

Too many in the scientific community, particularly those who control the funding, regard the commercialization of science as something "dirty," says the University of Leeds' Deputy Vice-Chancellor John Fisher in New Scientist. They say "that inspiration alone should be the driving force behind scientific labor," but this is just a "myth," Fisher says.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

A Model Organ

Lay It All Out

Different Approach

It'll Cost How Much?

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.